Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer
Liquid biopsy as a non-invasive method has a bright future in cancer diagnosis. Tumor-related extracellular vesicles (EVs) and their components (nucleic acids, proteins, and lipids) in biofluids may exert multiple functions in tumor growth, metastasis, immune escape, and angiogenesis. Among all the...
Main Authors: | Yanjun Diao, Bingbing Zhu, Ting Ding, Rui Li, Jinjie Li, Liu Yang, Lei Zhou, Xiaoke Hao, Jiayun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1201554/full |
Similar Items
-
Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines
by: Naoya Kuriyama, et al.
Published: (2021-12-01) -
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
by: Rong Du, et al.
Published: (2022-10-01) -
Extracellular vesicle‐based nucleic acid delivery
by: Mei Lu, et al.
Published: (2023-04-01) -
Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
by: Crescenzo Massaro, et al.
Published: (2020-10-01) -
Medium Extracellular Vesicles—A Qualitative and Quantitative Biomarker of Prostate Cancer
by: Milena Świtońska, et al.
Published: (2022-11-01)